Grant M. Gallagher

Despite a clear record of violations across the country, amid a culture where sick staff were asked to show up for work, lawmakers in several states have also potentially disincentivized improvement of infection control standards in long-term care facilities by providing legal liability protections ahead of time.

An existing US Food and Drug Administration (FDA) approved anticoagulant called Heparin may lower the odds of SARS-CoV-2 infection.

Matthew Pullen, MD: “After examining the data of our 821 participants, we did not find a significant difference in the risk of infection following exposure in those taking hydroxychloroquine and those taking placebo."

Health officials closely monitoring the situation.